Jefferies Reaffirms scPharmaceuticals (SCPH) As a “Buy”; They Now Have a Price Objective Of $12

June 14, 2018 - By Hazel Jackson

scPharmaceuticals (SCPH) Rating Reaffirmed

Equity analysts at Jefferies now has a $12 price target on scPharmaceuticals (SCPH). Jefferies and their recent price target would suggest a potential upside of 101.68 % from the company’s last stock price. The rating has been shown in a research report on Thursday morning.

scPharmaceuticals Inc. (NASDAQ:SCPH) Ratings Coverage

Among 2 analysts covering scPharmaceuticals Inc (SCPH), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. scPharmaceuticals Inc has $26.0 highest and $2000 lowest target. $23’s average target is 286.55% above currents $5.95 stock price. scPharmaceuticals Inc had 2 analyst reports since March 21, 2018 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Wednesday, March 21. Leerink Swann maintained the shares of SCPH in report on Wednesday, April 4 with “Buy” rating.

The stock increased 0.34% or $0.02 during the last trading session, reaching $5.95. About 227,359 shares traded or 36.67% up from the average. scPharmaceuticals Inc. (SCPH) has 0.00% since June 14, 2017 and is . It has underperformed by 12.57% the S&P500.

Analysts await scPharmaceuticals Inc. (NASDAQ:SCPH) to report earnings on August, 6. After $-0.47 actual earnings per share reported by scPharmaceuticals Inc. for the previous quarter, Wall Street now forecasts 34.04 % negative EPS growth.

scPharmaceuticals Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products. The company has market cap of $110.33 million. The company's under development products are for heart failure and infectious diseases that include Furoscix for the treatment of worsening or decompensated heart failure outside of the inpatient setting. in March 2014. It currently has negative earnings.

More notable recent scPharmaceuticals Inc. (NASDAQ:SCPH) news were published by: Nasdaq.com which released: “Mid-Morning Market Update: Markets Edge Higher; Korn/Ferry Beats Q4 Views” on June 13, 2018, also Benzinga.com with their article: “38 Biggest Movers From Yesterday” published on June 14, 2018, Nasdaq.com published: “Mid-Afternoon Market Update: J.Jill Climbs On Earnings Beat; Scpharmaceuticals Shares Fall” on May 31, 2018. More interesting news about scPharmaceuticals Inc. (NASDAQ:SCPH) were released by: Globenewswire.com and their article: “scPharmaceuticals Inc. Provides Regulatory Update on FUROSCIX®” published on May 31, 2018 as well as Benzinga.com‘s news article titled: “31 Stocks Moving In Wednesday’s Mid-Day Session” with publication date: June 13, 2018.

scPharmaceuticals Inc. (NASDAQ:SCPH) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: